Through a deeper understanding of disease we have identified therapeutic candidates for indications within AMD and linked diseases. Some targets also present in related diseases and help us to grow our pipeline organically.Our Pipeline
Gemini Therapeutics is a precision medicine company focused on the development of new therapies through a deeper understanding of disease. We are sharply focused on dry AMD which is a disease comprised of numerous genetic variants. We also believe that more precisely targeted therapeutics could better address the cause of a patient’s disease.